Fort Collins, CO, United States of America

David W Osborne

This inventor holds 43 USPTO granted patents and 33 published patent applications, plus 6 CIPO patents and 4 EPO patents, primarily in Dermatological Formulations. Top assignees: Arcutis Biotherapeutics, Inc., Arcutis, Inc., Dow Pharmaceutical Sciences, Inc.. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David W Osborne. Retrieved from https://idiyas.com/inventor/david-w-osborne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 43 (Patent Applications = 33)

% Patents Active = 79.1

CIPO Patents = 6 (Patent Applications = 15)

EPO Patents = 4 (Patent Applications = 16)

Average Co-Inventor Count = 1.3

ph-index = 13

Forward Citations = 401(Granted Patents)

Location History:

Santa Rosa, CA (US) (2007 - 2012)
Fort Collins, CO (US) (2002 - 2024)

Company Filing History:

27 out of 28

Arcutis Biotherapeutics, Inc.

Dow Pharmaceutical Sciences, Inc.

patents

4. 1 out of 26

Amderma Pharmaceuticals, LLC

patents

5. 1 out of 43

Atrix Laboratories, Inc.

patents

6. 1 out of 1

Axrix Laboratories, Inc.

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Topical Formulations

Roflumilast

Dermal Drug Delivery

Pharmacokinetics

Skin Penetration

Corticosteroids

Azithromycin

Aerosol Foams

Controlled Release

Antifungal Properties

UV Protection

Acne Treatment

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697329 - Method for reducing side effects from administration of phosphodiesterase-4 inhibitors (2026-08-04),

2. 12685727 - Method for reducing side effects from administration of phosphodiesterase-4 inhibitors (2026-07-21),

3. 12458652 - Pharmaceutical compositions of spironolactone for deep dermal drug delivery (2025-11-04),

4. 12453721 - Topical roflumilast aerosol foams (2025-10-28),

5. 12390453 - Method for reducing side effects from administration of phosphodiesterase-4 inhibitors (2025-08-19),

6. 12336983 - Inhibition of crystal growth of roflumilast (2025-06-24),

7. 12329751 - Topical roflumilast formulation having antifungal properties (2025-06-17),

8. 12310956 - Topical roflumilast formulation having improved delivery and plasma half-life (2025-05-27),

9. 12257242 - Inhibition of crystal growth of roflumilast (2025-03-25),

10. 12220409 - Roflumilast formulations with an improved pharmacokinetic profile (2025-02-11),

11. 12144802 - Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug (2024-11-19),

12. 12083122 - Laureth-4 containing topical formulations (2024-09-10),

13. 12053481 - Compositions and methods for deep dermal drug delivery (2024-08-06),

14. 12042558 - Method and formulation for improving roflumilast skin penetration lag time (2024-07-23),

15. 12042487 - Method for reducing side effects from administration of phosphodiesterase-4 inhibitors (2024-07-23),

Title: The Innovative Journey of David W Osborne

Introduction: David W Osborne, a talented inventor hailing from Fort Collins, CO (US), has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: David's latest patents focus on renewable energy solutions, with a series of inventions aimed at enhancing the efficiency of solar panels and wind turbines.

Career Highlights: With a background in mechanical engineering, David has spent over two decades working in the renewable energy sector. His career highlights include the development of a revolutionary energy storage system that has garnered international acclaim.

Collaborations: Throughout his career, David has collaborated with leading research institutions and universities to further his innovative projects. His partnerships have led to the creation of cutting-edge technologies that are shaping the future of sustainable energy.

Conclusion: David W Osborne's passion for innovation and commitment to sustainability have established him as a pioneering figure in the field of renewable energy. His inventive spirit continues to drive progress and inspire future generations of inventors.

Profile summary based on public USPTO records.